Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.28 - $18.9 $1.75 Million - $6.25 Million
-330,682 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$12.92 - $27.18 $1.32 Million - $2.77 Million
101,908 Added 44.55%
330,682 $5.81 Million
Q4 2021

Feb 14, 2022

SELL
$21.96 - $42.69 $1.12 Million - $2.18 Million
-51,000 Reduced 18.23%
228,774 $6.03 Million
Q3 2021

Nov 15, 2021

BUY
$41.3 - $54.56 $1.41 Million - $1.86 Million
34,033 Added 13.85%
279,774 $11.8 Million
Q2 2021

Aug 16, 2021

SELL
$38.61 - $55.0 $3.86 Million - $5.5 Million
-100,000 Reduced 28.92%
245,741 $13.3 Million
Q1 2021

May 17, 2021

SELL
$38.1 - $59.09 $10.7 Million - $16.6 Million
-280,850 Reduced 44.82%
345,741 $15.7 Million
Q4 2020

Feb 16, 2021

BUY
$33.26 - $59.72 $11.1 Million - $19.9 Million
333,453 Added 113.75%
626,591 $27.3 Million
Q3 2020

Nov 16, 2020

BUY
$0.55 - $41.34 $161,225 - $12.1 Million
293,138 New
293,138 $11.4 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $278M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.